Page 3 - in vivo research
-
September 01, 2022
Researchers from the Dana-Farber Cancer Institute and Harvard Medical School have conducted a comprehensive comparison of commonly used monoclonal antibodies (mAbs) targeting the PD-1/PD-L1 pathway in mice. Their findings, recently published in the journal Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, provide valuable insights for modeling cancer immunotherapy in preclinical studies.
The PD-1/PD-L1 pathway is a critical immune... -
July 20, 2022
Abstract:
Effective...
-
May 03, 2022
Navigating the Ethical Landscape of In Vivo Research: Balancing Scientific Advancement and Animal Welfare
Introduction:
In vivo research, which involves the use of live animals in scientific studies, has been instrumental in expanding our knowledge of biological systems, uncovering disease mechanisms, and developing novel therapies and interventions. From basic...
-
April 22, 2022
Introduction
In advancing cancer immunotherapy, antibodies against PD-1 have become a breakthrough and opened a new door for severely affected cancer patients. Nevertheless, the results of preclinical studies have faced various obstacles in transforming into successful clinical...
-
April 19, 2022
When selecting in vivo antibodies for research, it is essential to understand the differences between the two primary production methods: recombinant and hybridoma technologies. Each method has its own advantages and limitations that can impact the quality, consistency, and suitability of the antibodies for in vivo applications. This article will discuss the key differences between recombinant and hybridoma antibody production and their implications...
-
April 14, 2022
Abstract:
In vivo...
-
April 12, 2022
Selecting a reliable and reputable in vivo antibody supplier is crucial for ensuring the success and reproducibility of your research. The quality of the antibodies you use can significantly impact the outcomes of your in vivo studies, making it essential to choose a supplier that meets your specific requirements. This article will discuss the key factors to consider when evaluating in vivo antibody suppliers.
1. Quality control...
-
April 05, 2022
When conducting in vivo studies, selecting the appropriate antibodies is crucial to ensure the reliability and reproducibility of research findings. Researchers should carefully evaluate several key specifications before choosing in vivo antibodies to minimize the risk of adverse effects and optimize the quality of their results. This article will discuss the essential factors to consider when selecting in vivo antibodies.
1. Purity: Antibody... -
April 01, 2022
Introduction
As...